• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Jason Harris Highlights National Health Council's Recommendations on Real-World Evidence

Video

There still needs to be more education around what real-world evidence is, explained Jason Harris, associate director of policy and programs at National Health Council.

There still needs to be more education around what real-world evidence is, explained Jason Harris, associate director of policy and programs at National Health Council.

Transcript

What recommendations did the National Health Council come out with in its white paper on real-world evidence?

Recently, it’s been a real-world evidence year, if you will. We hosted a roundtable to solicit the patient perspective. We had close to 50 people in the room, about 15 experts from your more industry perspective and then about 30 patient organizations to just figure out what their concerns were, what their thoughts were, did they know about it. What we really learned from that is that overall, the concept is something that we need more education on, but once it’s explained and understood, it’s certainly something that patient organizations want to be involved in and we want to make sure that the ship doesn’t leave without insuring that perspective.

As you work with patients on real-world evidence, are you finding areas where their perceptions were not lined up with reality?

I think it’s a really good point. Overall, when we talk about the concept of what real-world evidence is and a patient hears that, they think for the most part it makes sense that it would be done because we are thinking of this high-tech era where we can use everything. It’s that understanding of well in healthcare, we are a little bit behind in terms of how we do things and so they were surprised that it wasn’t being done and that we weren’t quite there yet once they understood the concept.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.